抗血小板药物联合抗结核药治疗急性非ST段抬高型心肌梗死合并肺结核的药学监护  

Pharmaceutical care on anti-TB drugs combined with anti-platelet drug in the treatment of non-ST segment elevation acute myocardial infarction and pulmonary tuberculosis

作　　者：周靓昉 向倩[1] 何云霞[3] 谢秋芬[1] 王梓凝[1] 崔一民[1] ZHOU Liang- fang1＇2, XIANG Qianl, HE Yun - xia3, XIE Qiu - fen, WANG Zi - ning, CUI Yi - min(1. Department of Pharmacy, Peking University First Hospital, Beijing 100034, China; 2 Department of Pharmacy, Ningbo No. 6 Hospital, Ningbo 315040, China; 3. Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Science, Peking University, Beijing 100191, Chin)

机构地区：[1]北京大学第一医院药剂科,北京100034 [2]宁波市第六医院药剂科,宁波315040 [3]北京大学药学院药事管理与临床药学系,北京100191

出　　处：《中国临床药理学杂志》2018年第7期878-880,共3页The Chinese Journal of Clinical Pharmacology

基　　金：国家自然科学基金资助项目(81573504;81673509);北京市自然科学基金资助项目(7171012)

摘　　要：目的分析临床药师在急性非ST段抬高型心肌梗死合并肺结核患者的给药方案的制订与用药监护中的工作要点。方法临床药师参与1例急性非ST段抬高型心肌梗死合并肺结核患者的药物治疗过程,通过分析患者的治疗方案,评估抗血小板药物的疗效,讨论基因多态性以及抗结核药物与抗血小板药物之间的相互作用对疗效的影响。结果和结论分析每个药物的作用特点,恰当地管理药物相互作用,为患者提供个体化给药方案,是临床药师参与临床团队工作的切入点。Objective To explore the method of pharmaceutical care for patients with non -ST segment elevation acute myocardial infarction and pulmonary tuberculosis by clinical pharmacist. Methods Clinical phar- macist participated in an acute non - ST segment elevation myocardial infarction patients with pulmonary tuberculosis, analyzing the treatment options for patients, assessing the efficacy of anti - platelet drugs, discussing gene polymorphisms and the interactions efficacy between anti - TB drugs and anti - platelet drugs. Results and conclusion Analyzing the function and characteristics of each drug, managing of drug interactions, providing individual treatment strategies for patientssare the key points for clinical pharmacists participating in clinical work.

关 键 词：抗血小板药物 抗结核药物 氯吡格雷 替格瑞洛 药学监护 

分 类 号：R973.2[医药卫生—药品]